Risk-adapted scoring model to identify candidates benefiting from adjuvant chemotherapy after radical nephroureterectomy for localized upper urinary tract urothelial carcinoma: A multicenter study
Investigative and Clinical Urology · 2025
DOI: 10.4111/icu.20240323 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Investigative and Clinical Urology, 2025. Verfasst von Sung Jun Sou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea. Hauptthemen laut MEDLINE: Nephroureterectomy, Carcinoma, Transitional Cell, Ureteral Neoplasms, Kidney Neoplasms. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Urological Oncology Society.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
- Department of Urology, Dongnam Institute of Radiological & Medical Sciences Cancer Center, Busan, Korea.
- Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
- Department of Urology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Korea.
- Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
- Department of Urology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea. leechanho@naver.com.
ORCID-Profile: Sung Jun Sou, Ja Yoon Ku, Kyung Hwan Kim, Won Ik Seo, Hong Koo Ha, Hui Mo Gu, Eu Chang Hwang, Young Joo Park, Chan Ho Lee
Förderung
- Korean Urological Oncology Society
Zitieren
APA
Sou, S. J., Ku, J. Y., Kim, K. H., Seo, W. I., Ha, H. K., Gu, H. M., Hwang, E. C., Park, Y. J., & Lee, C. H. (2025). Risk-adapted scoring model to identify candidates benefiting from adjuvant chemotherapy after radical nephroureterectomy for localized upper urinary tract urothelial carcinoma: A multicenter study. Investigative and Clinical Urology. https://doi.org/10.4111/icu.20240323
Vancouver
Sou SJ, Ku JY, Kim KH, Seo WI, Ha HK, Gu HM, et al. Risk-adapted scoring model to identify candidates benefiting from adjuvant chemotherapy after radical nephroureterectomy for localized upper urinary tract urothelial carcinoma: A multicenter study. Investigative and Clinical Urology. 2025. doi:10.4111/icu.20240323
BibTeX
@article{Sou2025,
author = {Sou, Sung Jun and Ku, Ja Yoon and Kim, Kyung Hwan and Seo, Won Ik and Ha, Hong Koo and Gu, Hui Mo and Hwang, Eu Chang and Park, Young Joo and Lee, Chan Ho},
title = {Risk-adapted scoring model to identify candidates benefiting from adjuvant chemotherapy after radical nephroureterectomy for localized upper urinary tract urothelial carcinoma: A multicenter study},
journal = {Investigative and Clinical Urology},
year = {2025},
doi = {10.4111/icu.20240323}
}
EUVIMED